SPOTLIGHT: Quality control at Chinese heparin supplier

Curious how APP Pharmaceuticals' heparin supplier in China handles safety and quality control? Check out The Wall Street Journal's behind-the-scenes look at Shenzhen Hepalink Pharmaceutical. APP, remember, is supplying the lion's share of heparin in the U.S. in the wake of Baxter's big recall and production stoppage. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.